Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triiodothyronine Hormone Supplementation Therapy in Patients With Septic Shock With Euthyroid Sick Syndrome

NCT05270798 is registered in ClinicalTrials.gov with Cantonal Hospital Zenica as lead sponsor.

NCT NCT05270798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05270798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triiodothyronine Hormone Supplementation Therapy in Patients With Septic Shock With Euthyroid Sick Syndrome
Lead sponsor
Cantonal Hospital Zenica
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2022
Completion date
August 1, 2023
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

euthyroid sick syndromes, septic shock